nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—myenteric nerve plexus—colon cancer	0.0175	0.162	CbGeAlD
Paliperidone—HTR2A—vein—colon cancer	0.0113	0.104	CbGeAlD
Paliperidone—HTR1B—blood vessel—colon cancer	0.00743	0.0689	CbGeAlD
Paliperidone—HTR1D—blood vessel—colon cancer	0.00719	0.0668	CbGeAlD
Paliperidone—ADRA1B—renal system—colon cancer	0.00444	0.0412	CbGeAlD
Paliperidone—HTR2A—endothelium—colon cancer	0.00387	0.036	CbGeAlD
Paliperidone—HTR2A—blood vessel—colon cancer	0.00357	0.0332	CbGeAlD
Paliperidone—HTR1A—renal system—colon cancer	0.00271	0.0251	CbGeAlD
Paliperidone—ADRA1A—epithelium—colon cancer	0.00269	0.025	CbGeAlD
Paliperidone—ADRA1A—renal system—colon cancer	0.0025	0.0232	CbGeAlD
Paliperidone—ADRA2C—renal system—colon cancer	0.00238	0.0221	CbGeAlD
Paliperidone—HTR2A—embryo—colon cancer	0.00213	0.0198	CbGeAlD
Paliperidone—HRH1—epithelium—colon cancer	0.00208	0.0193	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—colon cancer	0.00207	0.0192	CbGeAlD
Paliperidone—HRH1—smooth muscle tissue—colon cancer	0.00201	0.0186	CbGeAlD
Paliperidone—CYP3A5—renal system—colon cancer	0.00199	0.0185	CbGeAlD
Paliperidone—HTR2A—epithelium—colon cancer	0.00174	0.0161	CbGeAlD
Paliperidone—ADRA2C—vagina—colon cancer	0.00172	0.016	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—colon cancer	0.00168	0.0156	CbGeAlD
Paliperidone—CYP3A5—digestive system—colon cancer	0.00163	0.0151	CbGeAlD
Paliperidone—HTR2A—renal system—colon cancer	0.00161	0.015	CbGeAlD
Paliperidone—HRH1—digestive system—colon cancer	0.00158	0.0147	CbGeAlD
Paliperidone—Risperidone—ABCB1—colon cancer	0.00157	1	CrCbGaD
Paliperidone—ADRA1A—liver—colon cancer	0.00152	0.0141	CbGeAlD
Paliperidone—CYP3A4—renal system—colon cancer	0.00149	0.0139	CbGeAlD
Paliperidone—CYP2D6—renal system—colon cancer	0.00147	0.0136	CbGeAlD
Paliperidone—ADRA2C—liver—colon cancer	0.00145	0.0135	CbGeAlD
Paliperidone—CYP3A5—vagina—colon cancer	0.00144	0.0134	CbGeAlD
Paliperidone—Infection—Vincristine—colon cancer	0.00141	0.00158	CcSEcCtD
Paliperidone—Urinary tract infection—Capecitabine—colon cancer	0.00141	0.00158	CcSEcCtD
Paliperidone—Conjunctivitis—Capecitabine—colon cancer	0.00141	0.00158	CcSEcCtD
Paliperidone—Convulsion—Fluorouracil—colon cancer	0.0014	0.00158	CcSEcCtD
Paliperidone—Osteoarthritis—Methotrexate—colon cancer	0.0014	0.00157	CcSEcCtD
Paliperidone—HRH1—vagina—colon cancer	0.0014	0.013	CbGeAlD
Paliperidone—Confusional state—Irinotecan—colon cancer	0.00139	0.00156	CcSEcCtD
Paliperidone—Nervous system disorder—Vincristine—colon cancer	0.00139	0.00156	CcSEcCtD
Paliperidone—Thrombocytopenia—Vincristine—colon cancer	0.00139	0.00156	CcSEcCtD
Paliperidone—Anaphylactic shock—Irinotecan—colon cancer	0.00138	0.00155	CcSEcCtD
Paliperidone—Oedema—Irinotecan—colon cancer	0.00138	0.00155	CcSEcCtD
Paliperidone—Chest pain—Fluorouracil—colon cancer	0.00138	0.00155	CcSEcCtD
Paliperidone—Myalgia—Fluorouracil—colon cancer	0.00138	0.00155	CcSEcCtD
Paliperidone—ADRA2A—vagina—colon cancer	0.00137	0.0128	CbGeAlD
Paliperidone—Infection—Irinotecan—colon cancer	0.00137	0.00154	CcSEcCtD
Paliperidone—Hepatobiliary disease—Capecitabine—colon cancer	0.00137	0.00154	CcSEcCtD
Paliperidone—Epistaxis—Capecitabine—colon cancer	0.00137	0.00153	CcSEcCtD
Paliperidone—Discomfort—Fluorouracil—colon cancer	0.00136	0.00153	CcSEcCtD
Paliperidone—Shock—Irinotecan—colon cancer	0.00136	0.00153	CcSEcCtD
Paliperidone—Nervous system disorder—Irinotecan—colon cancer	0.00135	0.00152	CcSEcCtD
Paliperidone—Agranulocytosis—Capecitabine—colon cancer	0.00135	0.00152	CcSEcCtD
Paliperidone—Thrombocytopenia—Irinotecan—colon cancer	0.00135	0.00152	CcSEcCtD
Paliperidone—Anorexia—Vincristine—colon cancer	0.00135	0.00152	CcSEcCtD
Paliperidone—Confusional state—Fluorouracil—colon cancer	0.00133	0.0015	CcSEcCtD
Paliperidone—Hypotension—Vincristine—colon cancer	0.00133	0.00149	CcSEcCtD
Paliperidone—Bradycardia—Capecitabine—colon cancer	0.00132	0.00149	CcSEcCtD
Paliperidone—HTR2A—digestive system—colon cancer	0.00132	0.0123	CbGeAlD
Paliperidone—Anaphylactic shock—Fluorouracil—colon cancer	0.00132	0.00149	CcSEcCtD
Paliperidone—Oedema—Fluorouracil—colon cancer	0.00132	0.00149	CcSEcCtD
Paliperidone—Anorexia—Irinotecan—colon cancer	0.00132	0.00148	CcSEcCtD
Paliperidone—Infection—Fluorouracil—colon cancer	0.00131	0.00148	CcSEcCtD
Paliperidone—Rhinitis—Capecitabine—colon cancer	0.0013	0.00146	CcSEcCtD
Paliperidone—Nervous system disorder—Fluorouracil—colon cancer	0.0013	0.00146	CcSEcCtD
Paliperidone—Thrombocytopenia—Fluorouracil—colon cancer	0.0013	0.00145	CcSEcCtD
Paliperidone—Hypoaesthesia—Capecitabine—colon cancer	0.00129	0.00145	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00129	0.00145	CcSEcCtD
Paliperidone—Tachycardia—Fluorouracil—colon cancer	0.00129	0.00145	CcSEcCtD
Paliperidone—Hypotension—Irinotecan—colon cancer	0.00129	0.00145	CcSEcCtD
Paliperidone—Urinary tract disorder—Capecitabine—colon cancer	0.00128	0.00144	CcSEcCtD
Paliperidone—Insomnia—Vincristine—colon cancer	0.00128	0.00144	CcSEcCtD
Paliperidone—Oedema peripheral—Capecitabine—colon cancer	0.00128	0.00144	CcSEcCtD
Paliperidone—Connective tissue disorder—Capecitabine—colon cancer	0.00128	0.00144	CcSEcCtD
Paliperidone—Urethral disorder—Capecitabine—colon cancer	0.00128	0.00143	CcSEcCtD
Paliperidone—Paraesthesia—Vincristine—colon cancer	0.00127	0.00143	CcSEcCtD
Paliperidone—Breast disorder—Methotrexate—colon cancer	0.00127	0.00142	CcSEcCtD
Paliperidone—Anorexia—Fluorouracil—colon cancer	0.00126	0.00142	CcSEcCtD
Paliperidone—Insomnia—Irinotecan—colon cancer	0.00125	0.0014	CcSEcCtD
Paliperidone—Paraesthesia—Irinotecan—colon cancer	0.00124	0.00139	CcSEcCtD
Paliperidone—Hypotension—Fluorouracil—colon cancer	0.00124	0.00139	CcSEcCtD
Paliperidone—Decreased appetite—Vincristine—colon cancer	0.00123	0.00138	CcSEcCtD
Paliperidone—Dyspnoea—Irinotecan—colon cancer	0.00123	0.00138	CcSEcCtD
Paliperidone—Somnolence—Irinotecan—colon cancer	0.00123	0.00138	CcSEcCtD
Paliperidone—CYP3A4—digestive system—colon cancer	0.00122	0.0114	CbGeAlD
Paliperidone—Gastrointestinal disorder—Vincristine—colon cancer	0.00122	0.00137	CcSEcCtD
Paliperidone—Fatigue—Vincristine—colon cancer	0.00122	0.00137	CcSEcCtD
Paliperidone—CYP3A5—liver—colon cancer	0.00122	0.0113	CbGeAlD
Paliperidone—Eye disorder—Capecitabine—colon cancer	0.00122	0.00137	CcSEcCtD
Paliperidone—Dyspepsia—Irinotecan—colon cancer	0.00122	0.00136	CcSEcCtD
Paliperidone—Tinnitus—Capecitabine—colon cancer	0.00121	0.00136	CcSEcCtD
Paliperidone—Constipation—Vincristine—colon cancer	0.00121	0.00136	CcSEcCtD
Paliperidone—Pain—Vincristine—colon cancer	0.00121	0.00136	CcSEcCtD
Paliperidone—Flushing—Capecitabine—colon cancer	0.00121	0.00136	CcSEcCtD
Paliperidone—Cardiac disorder—Capecitabine—colon cancer	0.00121	0.00136	CcSEcCtD
Paliperidone—CYP2D6—digestive system—colon cancer	0.00121	0.0112	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00121	0.00135	CcSEcCtD
Paliperidone—Decreased appetite—Irinotecan—colon cancer	0.0012	0.00135	CcSEcCtD
Paliperidone—Insomnia—Fluorouracil—colon cancer	0.0012	0.00134	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00119	0.00134	CcSEcCtD
Paliperidone—Fatigue—Irinotecan—colon cancer	0.00119	0.00134	CcSEcCtD
Paliperidone—Paraesthesia—Fluorouracil—colon cancer	0.00119	0.00133	CcSEcCtD
Paliperidone—Pancreatitis—Methotrexate—colon cancer	0.00119	0.00133	CcSEcCtD
Paliperidone—Pain—Irinotecan—colon cancer	0.00118	0.00133	CcSEcCtD
Paliperidone—Constipation—Irinotecan—colon cancer	0.00118	0.00133	CcSEcCtD
Paliperidone—Angiopathy—Capecitabine—colon cancer	0.00118	0.00133	CcSEcCtD
Paliperidone—Dyspnoea—Fluorouracil—colon cancer	0.00118	0.00132	CcSEcCtD
Paliperidone—Somnolence—Fluorouracil—colon cancer	0.00118	0.00132	CcSEcCtD
Paliperidone—Immune system disorder—Capecitabine—colon cancer	0.00118	0.00132	CcSEcCtD
Paliperidone—Mediastinal disorder—Capecitabine—colon cancer	0.00117	0.00132	CcSEcCtD
Paliperidone—HTR2A—vagina—colon cancer	0.00117	0.0108	CbGeAlD
Paliperidone—Chills—Capecitabine—colon cancer	0.00117	0.00131	CcSEcCtD
Paliperidone—Dyspepsia—Fluorouracil—colon cancer	0.00116	0.00131	CcSEcCtD
Paliperidone—Abdominal discomfort—Methotrexate—colon cancer	0.00116	0.0013	CcSEcCtD
Paliperidone—Gastrointestinal pain—Vincristine—colon cancer	0.00116	0.0013	CcSEcCtD
Paliperidone—Decreased appetite—Fluorouracil—colon cancer	0.00115	0.00129	CcSEcCtD
Paliperidone—Alopecia—Capecitabine—colon cancer	0.00115	0.00129	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00114	0.00128	CcSEcCtD
Paliperidone—Mental disorder—Capecitabine—colon cancer	0.00114	0.00128	CcSEcCtD
Paliperidone—Feeling abnormal—Irinotecan—colon cancer	0.00114	0.00128	CcSEcCtD
Paliperidone—Malnutrition—Capecitabine—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Erythema—Capecitabine—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Dysuria—Methotrexate—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Neutropenia—Methotrexate—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Pain—Fluorouracil—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Gastrointestinal pain—Irinotecan—colon cancer	0.00113	0.00127	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Methotrexate—colon cancer	0.00112	0.00126	CcSEcCtD
Paliperidone—Abdominal pain—Vincristine—colon cancer	0.00112	0.00126	CcSEcCtD
Paliperidone—Body temperature increased—Vincristine—colon cancer	0.00112	0.00126	CcSEcCtD
Paliperidone—Flatulence—Capecitabine—colon cancer	0.00112	0.00125	CcSEcCtD
Paliperidone—Erectile dysfunction—Methotrexate—colon cancer	0.00111	0.00125	CcSEcCtD
Paliperidone—ADRA2C—lymph node—colon cancer	0.00111	0.0103	CbGeAlD
Paliperidone—Dysgeusia—Capecitabine—colon cancer	0.00111	0.00125	CcSEcCtD
Paliperidone—Back pain—Capecitabine—colon cancer	0.0011	0.00123	CcSEcCtD
Paliperidone—Abdominal pain—Irinotecan—colon cancer	0.00109	0.00123	CcSEcCtD
Paliperidone—Body temperature increased—Irinotecan—colon cancer	0.00109	0.00123	CcSEcCtD
Paliperidone—Feeling abnormal—Fluorouracil—colon cancer	0.00109	0.00122	CcSEcCtD
Paliperidone—Muscle spasms—Capecitabine—colon cancer	0.00109	0.00122	CcSEcCtD
Paliperidone—Pneumonia—Methotrexate—colon cancer	0.00109	0.00122	CcSEcCtD
Paliperidone—Infestation NOS—Methotrexate—colon cancer	0.00108	0.00121	CcSEcCtD
Paliperidone—Infestation—Methotrexate—colon cancer	0.00108	0.00121	CcSEcCtD
Paliperidone—Depression—Methotrexate—colon cancer	0.00108	0.00121	CcSEcCtD
Paliperidone—Vision blurred—Capecitabine—colon cancer	0.00107	0.0012	CcSEcCtD
Paliperidone—Tremor—Capecitabine—colon cancer	0.00106	0.00119	CcSEcCtD
Paliperidone—Ill-defined disorder—Capecitabine—colon cancer	0.00105	0.00118	CcSEcCtD
Paliperidone—Urticaria—Fluorouracil—colon cancer	0.00105	0.00118	CcSEcCtD
Paliperidone—Conjunctivitis—Methotrexate—colon cancer	0.00105	0.00118	CcSEcCtD
Paliperidone—Anaemia—Capecitabine—colon cancer	0.00105	0.00118	CcSEcCtD
Paliperidone—Body temperature increased—Fluorouracil—colon cancer	0.00105	0.00117	CcSEcCtD
Paliperidone—Hypersensitivity—Vincristine—colon cancer	0.00104	0.00117	CcSEcCtD
Paliperidone—Malaise—Capecitabine—colon cancer	0.00102	0.00115	CcSEcCtD
Paliperidone—Hepatobiliary disease—Methotrexate—colon cancer	0.00102	0.00115	CcSEcCtD
Paliperidone—Epistaxis—Methotrexate—colon cancer	0.00102	0.00114	CcSEcCtD
Paliperidone—Vertigo—Capecitabine—colon cancer	0.00102	0.00114	CcSEcCtD
Paliperidone—Hypersensitivity—Irinotecan—colon cancer	0.00102	0.00114	CcSEcCtD
Paliperidone—Asthenia—Vincristine—colon cancer	0.00102	0.00114	CcSEcCtD
Paliperidone—Syncope—Capecitabine—colon cancer	0.00102	0.00114	CcSEcCtD
Paliperidone—Leukopenia—Capecitabine—colon cancer	0.00101	0.00114	CcSEcCtD
Paliperidone—Agranulocytosis—Methotrexate—colon cancer	0.00101	0.00113	CcSEcCtD
Paliperidone—Palpitations—Capecitabine—colon cancer	0.001	0.00112	CcSEcCtD
Paliperidone—Loss of consciousness—Capecitabine—colon cancer	0.000995	0.00112	CcSEcCtD
Paliperidone—Asthenia—Irinotecan—colon cancer	0.000991	0.00111	CcSEcCtD
Paliperidone—Cough—Capecitabine—colon cancer	0.000988	0.00111	CcSEcCtD
Paliperidone—HTR2A—liver—colon cancer	0.000986	0.00915	CbGeAlD
Paliperidone—Hypertension—Capecitabine—colon cancer	0.000978	0.0011	CcSEcCtD
Paliperidone—Hypersensitivity—Fluorouracil—colon cancer	0.000975	0.00109	CcSEcCtD
Paliperidone—Diarrhoea—Vincristine—colon cancer	0.00097	0.00109	CcSEcCtD
Paliperidone—Myalgia—Capecitabine—colon cancer	0.000964	0.00108	CcSEcCtD
Paliperidone—Chest pain—Capecitabine—colon cancer	0.000964	0.00108	CcSEcCtD
Paliperidone—Arthralgia—Capecitabine—colon cancer	0.000964	0.00108	CcSEcCtD
Paliperidone—Anxiety—Capecitabine—colon cancer	0.000961	0.00108	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000958	0.00108	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—colon cancer	0.000957	0.00107	CcSEcCtD
Paliperidone—Discomfort—Capecitabine—colon cancer	0.000953	0.00107	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—colon cancer	0.000949	0.00107	CcSEcCtD
Paliperidone—Diarrhoea—Irinotecan—colon cancer	0.000945	0.00106	CcSEcCtD
Paliperidone—Dry mouth—Capecitabine—colon cancer	0.000943	0.00106	CcSEcCtD
Paliperidone—Dizziness—Vincristine—colon cancer	0.000938	0.00105	CcSEcCtD
Paliperidone—Pruritus—Fluorouracil—colon cancer	0.000936	0.00105	CcSEcCtD
Paliperidone—Confusional state—Capecitabine—colon cancer	0.000932	0.00105	CcSEcCtD
Paliperidone—Oedema—Capecitabine—colon cancer	0.000924	0.00104	CcSEcCtD
Paliperidone—Infection—Capecitabine—colon cancer	0.000918	0.00103	CcSEcCtD
Paliperidone—Dizziness—Irinotecan—colon cancer	0.000913	0.00103	CcSEcCtD
Paliperidone—CYP3A4—liver—colon cancer	0.000913	0.00847	CbGeAlD
Paliperidone—Shock—Capecitabine—colon cancer	0.000909	0.00102	CcSEcCtD
Paliperidone—Nervous system disorder—Capecitabine—colon cancer	0.000907	0.00102	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—colon cancer	0.000905	0.00102	CcSEcCtD
Paliperidone—Diarrhoea—Fluorouracil—colon cancer	0.000905	0.00102	CcSEcCtD
Paliperidone—Thrombocytopenia—Capecitabine—colon cancer	0.000905	0.00102	CcSEcCtD
Paliperidone—HRH1—lymph node—colon cancer	0.000905	0.0084	CbGeAlD
Paliperidone—Tinnitus—Methotrexate—colon cancer	0.000903	0.00101	CcSEcCtD
Paliperidone—Tachycardia—Capecitabine—colon cancer	0.000902	0.00101	CcSEcCtD
Paliperidone—Vomiting—Vincristine—colon cancer	0.000902	0.00101	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—colon cancer	0.000899	0.00101	CcSEcCtD
Paliperidone—CYP2D6—liver—colon cancer	0.000898	0.00833	CbGeAlD
Paliperidone—Skin disorder—Capecitabine—colon cancer	0.000898	0.00101	CcSEcCtD
Paliperidone—Rash—Vincristine—colon cancer	0.000894	0.001	CcSEcCtD
Paliperidone—Dermatitis—Vincristine—colon cancer	0.000893	0.001	CcSEcCtD
Paliperidone—ADRA2A—lymph node—colon cancer	0.000889	0.00825	CbGeAlD
Paliperidone—Headache—Vincristine—colon cancer	0.000888	0.000997	CcSEcCtD
Paliperidone—Anorexia—Capecitabine—colon cancer	0.000881	0.000989	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—colon cancer	0.000879	0.000987	CcSEcCtD
Paliperidone—Vomiting—Irinotecan—colon cancer	0.000878	0.000986	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—colon cancer	0.000875	0.000982	CcSEcCtD
Paliperidone—Dizziness—Fluorouracil—colon cancer	0.000875	0.000982	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—colon cancer	0.000873	0.00098	CcSEcCtD
Paliperidone—Rash—Irinotecan—colon cancer	0.000871	0.000978	CcSEcCtD
Paliperidone—Dermatitis—Irinotecan—colon cancer	0.00087	0.000977	CcSEcCtD
Paliperidone—Chills—Methotrexate—colon cancer	0.000869	0.000976	CcSEcCtD
Paliperidone—Headache—Irinotecan—colon cancer	0.000865	0.000971	CcSEcCtD
Paliperidone—Hypotension—Capecitabine—colon cancer	0.000864	0.00097	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—colon cancer	0.000856	0.000961	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—colon cancer	0.000849	0.000953	CcSEcCtD
Paliperidone—Erythema—Methotrexate—colon cancer	0.000843	0.000947	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—colon cancer	0.000843	0.000947	CcSEcCtD
Paliperidone—Nausea—Vincristine—colon cancer	0.000842	0.000946	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000842	0.000946	CcSEcCtD
Paliperidone—Vomiting—Fluorouracil—colon cancer	0.000841	0.000944	CcSEcCtD
Paliperidone—Insomnia—Capecitabine—colon cancer	0.000836	0.000939	CcSEcCtD
Paliperidone—Rash—Fluorouracil—colon cancer	0.000834	0.000936	CcSEcCtD
Paliperidone—Dermatitis—Fluorouracil—colon cancer	0.000833	0.000936	CcSEcCtD
Paliperidone—Paraesthesia—Capecitabine—colon cancer	0.00083	0.000932	CcSEcCtD
Paliperidone—Headache—Fluorouracil—colon cancer	0.000829	0.00093	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—colon cancer	0.000826	0.000927	CcSEcCtD
Paliperidone—Dyspnoea—Capecitabine—colon cancer	0.000824	0.000925	CcSEcCtD
Paliperidone—Nausea—Irinotecan—colon cancer	0.00082	0.000921	CcSEcCtD
Paliperidone—Back pain—Methotrexate—colon cancer	0.000816	0.000916	CcSEcCtD
Paliperidone—Dyspepsia—Capecitabine—colon cancer	0.000814	0.000914	CcSEcCtD
Paliperidone—Decreased appetite—Capecitabine—colon cancer	0.000804	0.000902	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000798	0.000896	CcSEcCtD
Paliperidone—Fatigue—Capecitabine—colon cancer	0.000797	0.000895	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—colon cancer	0.000795	0.000892	CcSEcCtD
Paliperidone—Pain—Capecitabine—colon cancer	0.00079	0.000887	CcSEcCtD
Paliperidone—Constipation—Capecitabine—colon cancer	0.00079	0.000887	CcSEcCtD
Paliperidone—Nausea—Fluorouracil—colon cancer	0.000786	0.000882	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—colon cancer	0.000782	0.000878	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—colon cancer	0.000779	0.000875	CcSEcCtD
Paliperidone—Feeling abnormal—Capecitabine—colon cancer	0.000762	0.000855	CcSEcCtD
Paliperidone—Malaise—Methotrexate—colon cancer	0.00076	0.000854	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—colon cancer	0.000758	0.000851	CcSEcCtD
Paliperidone—Gastrointestinal pain—Capecitabine—colon cancer	0.000756	0.000849	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—colon cancer	0.000755	0.000847	CcSEcCtD
Paliperidone—Cough—Methotrexate—colon cancer	0.000736	0.000826	CcSEcCtD
Paliperidone—Urticaria—Capecitabine—colon cancer	0.000734	0.000824	CcSEcCtD
Paliperidone—Abdominal pain—Capecitabine—colon cancer	0.000731	0.00082	CcSEcCtD
Paliperidone—Body temperature increased—Capecitabine—colon cancer	0.000731	0.00082	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—colon cancer	0.000731	0.00082	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—colon cancer	0.000718	0.000806	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—colon cancer	0.000718	0.000806	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—colon cancer	0.000718	0.000806	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000713	0.0008	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—colon cancer	0.000709	0.000796	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—colon cancer	0.000694	0.000779	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—colon cancer	0.000688	0.000773	CcSEcCtD
Paliperidone—Infection—Methotrexate—colon cancer	0.000684	0.000768	CcSEcCtD
Paliperidone—Hypersensitivity—Capecitabine—colon cancer	0.000681	0.000765	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—colon cancer	0.000675	0.000758	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—colon cancer	0.000674	0.000756	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—colon cancer	0.000668	0.00075	CcSEcCtD
Paliperidone—Asthenia—Capecitabine—colon cancer	0.000663	0.000745	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—colon cancer	0.000656	0.000736	CcSEcCtD
Paliperidone—Pruritus—Capecitabine—colon cancer	0.000654	0.000734	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—colon cancer	0.000643	0.000722	CcSEcCtD
Paliperidone—Diarrhoea—Capecitabine—colon cancer	0.000632	0.00071	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000627	0.000704	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—colon cancer	0.000622	0.000699	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—colon cancer	0.000618	0.000694	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—colon cancer	0.000613	0.000689	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—colon cancer	0.000612	0.000687	CcSEcCtD
Paliperidone—Dizziness—Capecitabine—colon cancer	0.000611	0.000686	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—colon cancer	0.000606	0.00068	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—colon cancer	0.000598	0.000672	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000594	0.000667	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—colon cancer	0.000593	0.000666	CcSEcCtD
Paliperidone—Pain—Methotrexate—colon cancer	0.000588	0.000661	CcSEcCtD
Paliperidone—Vomiting—Capecitabine—colon cancer	0.000588	0.00066	CcSEcCtD
Paliperidone—Rash—Capecitabine—colon cancer	0.000583	0.000654	CcSEcCtD
Paliperidone—Dermatitis—Capecitabine—colon cancer	0.000582	0.000654	CcSEcCtD
Paliperidone—Headache—Capecitabine—colon cancer	0.000579	0.00065	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—colon cancer	0.000567	0.000637	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—colon cancer	0.000563	0.000632	CcSEcCtD
Paliperidone—Nausea—Capecitabine—colon cancer	0.000549	0.000616	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—colon cancer	0.000547	0.000614	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—colon cancer	0.000544	0.000611	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—colon cancer	0.000544	0.000611	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—colon cancer	0.000507	0.000569	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—colon cancer	0.000494	0.000554	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—colon cancer	0.000487	0.000547	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—colon cancer	0.000471	0.000529	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—colon cancer	0.000455	0.000511	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—colon cancer	0.000438	0.000491	CcSEcCtD
Paliperidone—Rash—Methotrexate—colon cancer	0.000434	0.000487	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—colon cancer	0.000433	0.000487	CcSEcCtD
Paliperidone—Headache—Methotrexate—colon cancer	0.000431	0.000484	CcSEcCtD
Paliperidone—Nausea—Methotrexate—colon cancer	0.000409	0.000459	CcSEcCtD
